Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vincent, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vincent, J. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 41, 9-15, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy

ORIGINAL ARTICLES

Cardiovascular alterations in septic shock

JL Vincent
Department of Intensive Care, Erasme University Hospital, Brussels, Belgium. jlvincen@resulb.ulb.ac.be

Cardiovascular alterations in sepsis include a decrease in vascular tone and an impairment in myocardial contractility, and occur largely as the result of the release and action of mediators of the sepsis cascade. Many mediators are involved including cytokines, particularly tumour necrosis factor and interleukin-1, and secondary mediators such as nitric oxide and oxygen free radicals. The degree of reduced vascular tone and myocardial depression have both been related to the severity of sepsis. In this article we will review current knowledge on the factors involved in the cardiovascular alterations of sepsis, the clinical implications of these alterations, and the possibilities for future treatments.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
C. C. McGown and Z. L. S. Brookes
Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide
Br. J. Anaesth., February 1, 2007; 98(2): 163 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
L. Jia, M. Takahashi, H. Morimoto, S. Takahashi, A. Izawa, H. Ise, T. Iwasaki, H. Hattori, K.-J. Wu, and U. Ikeda
Changes in cardiac lipid metabolism during sepsis: The essential role of very low-density lipoprotein receptors
Cardiovasc Res, February 1, 2006; 69(2): 545 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
V. Brovkovych, L. W. Dobrucki, S. Brovkovych, I. Dobrucki, L. Kalinowski, F. Kiechle, and T. Malinski
Nitric Oxide Measurements during Endotoxemia
Clin. Chem., June 1, 2001; 47(6): 1068 - 1074.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.